Conference Coverage

ONC-CHAT: What Did You Learn this Week that Will Change the Way You Work?

Publish date: December 8, 2012

 

AT THE SAN ANTONIO BREAST CANCER SYMPOSIUM

Our reporter Michele Sullivan closes out the San Antonio Breast Cancer Symposium by asking attendees what they learned at the meeting that will change the way they work.

Recommended Reading

Bevacizumab Adds No Progression, Survival Benefits to Estrogen Therapy
MDedge Hematology and Oncology
Mammograms Dip in Wake of USPSTF Recommendations
MDedge Hematology and Oncology
San Antonio Roundtable, Part 2: CALOR Trial, Triple-Negative Breast Cancer
MDedge Hematology and Oncology
PET/CT Pinpoints Physiological Evidence of Chemo Brain
MDedge Hematology and Oncology
San Antonio Roundtable, Part 3: Trastuzumab, Bevacizumab, and Angiogenesis Inhibitors
MDedge Hematology and Oncology
ONC-CHAT: 'VOGL, NEW YORK' on 10 Years of Tamoxifen
MDedge Hematology and Oncology
ONC-CHAT: What Captured Your Imagination?
MDedge Hematology and Oncology
Genetic Vulnerabilities Identified in Residual TNBC After Neoadjuvant Chemo
MDedge Hematology and Oncology
Late Leukemia Risk Rises after Breast Cancer Therapy
MDedge Hematology and Oncology
San Antonio Roundtable, Part 4: Everolimus in Clinical Practice, a New CDK Inhibitor
MDedge Hematology and Oncology